| Dr Caroline Topolinski, CRNA | |
|
4315 Diplomacy Dr, Anchorage, AK 99508-5926 | |
| (907) 563-2662 | |
| Not Available |
| Full Name | Dr Caroline Topolinski |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 4 Years |
| Location | 4315 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427669993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 193364 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alaska Native Medical Center | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Native Tribal Health Consortium | 6709780265 | 457 |
News Archive
Sapheon Inc. announced that it has received CE Mark approval for its new approach to the treatment of varicose veins caused by venous reflux disease.
Technology Catalysts International (TCI), leading global consultants to the pharmaceutical industry, announced that research on cancer trends and development has identified cancer vaccines as a viable treatment option for a variety of cancers that currently have ineffective treatments. The potential of the cancer vaccine market is forecast to approach $3 billion in 2015.
The National Institutes of Health recently awarded $46.5 million to the University of Colorado Anschutz Medical Campus and its Colorado Clinical and Translational Sciences Institute, a research partnership designed to speed up development of new treatments to address the greatest health needs of Coloradans.
Despite a recent ban on the sale of menthol cigarettes in the Canadian provinces of Alberta and Nova Scotia, cigarettes made with similar coloring and marketed as having the same taste are still being sold, new research from the Institute for Global Tobacco Control at the Johns Hopkins Bloomberg School of Public Health suggests.
A highly lethal cancer sometimes requires large doses of highly toxic drugs. However, a blitzkrieg approach can be unfeasible for some patients due to severe side effects. Now a powerhouse team of researchers at the University of North Carolina at Chapel Hill has revealed that an implantable device can deliver a particularly toxic cocktail of drugs directly to pancreatic tumors to stunt their growth or in some cases, shrink them - all while showing signs that the rest of the body would be spared toxic side effects.
› Verified 8 days ago
| Entity Name | Alaska Native Tribal Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
Sapheon Inc. announced that it has received CE Mark approval for its new approach to the treatment of varicose veins caused by venous reflux disease.
Technology Catalysts International (TCI), leading global consultants to the pharmaceutical industry, announced that research on cancer trends and development has identified cancer vaccines as a viable treatment option for a variety of cancers that currently have ineffective treatments. The potential of the cancer vaccine market is forecast to approach $3 billion in 2015.
The National Institutes of Health recently awarded $46.5 million to the University of Colorado Anschutz Medical Campus and its Colorado Clinical and Translational Sciences Institute, a research partnership designed to speed up development of new treatments to address the greatest health needs of Coloradans.
Despite a recent ban on the sale of menthol cigarettes in the Canadian provinces of Alberta and Nova Scotia, cigarettes made with similar coloring and marketed as having the same taste are still being sold, new research from the Institute for Global Tobacco Control at the Johns Hopkins Bloomberg School of Public Health suggests.
A highly lethal cancer sometimes requires large doses of highly toxic drugs. However, a blitzkrieg approach can be unfeasible for some patients due to severe side effects. Now a powerhouse team of researchers at the University of North Carolina at Chapel Hill has revealed that an implantable device can deliver a particularly toxic cocktail of drugs directly to pancreatic tumors to stunt their growth or in some cases, shrink them - all while showing signs that the rest of the body would be spared toxic side effects.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Caroline Topolinski, CRNA 7415 River Park Cir, Eagle River, AK 99577-9416 Ph: () - | Dr Caroline Topolinski, CRNA 4315 Diplomacy Dr, Anchorage, AK 99508-5926 Ph: (907) 563-2662 |
News Archive
Sapheon Inc. announced that it has received CE Mark approval for its new approach to the treatment of varicose veins caused by venous reflux disease.
Technology Catalysts International (TCI), leading global consultants to the pharmaceutical industry, announced that research on cancer trends and development has identified cancer vaccines as a viable treatment option for a variety of cancers that currently have ineffective treatments. The potential of the cancer vaccine market is forecast to approach $3 billion in 2015.
The National Institutes of Health recently awarded $46.5 million to the University of Colorado Anschutz Medical Campus and its Colorado Clinical and Translational Sciences Institute, a research partnership designed to speed up development of new treatments to address the greatest health needs of Coloradans.
Despite a recent ban on the sale of menthol cigarettes in the Canadian provinces of Alberta and Nova Scotia, cigarettes made with similar coloring and marketed as having the same taste are still being sold, new research from the Institute for Global Tobacco Control at the Johns Hopkins Bloomberg School of Public Health suggests.
A highly lethal cancer sometimes requires large doses of highly toxic drugs. However, a blitzkrieg approach can be unfeasible for some patients due to severe side effects. Now a powerhouse team of researchers at the University of North Carolina at Chapel Hill has revealed that an implantable device can deliver a particularly toxic cocktail of drugs directly to pancreatic tumors to stunt their growth or in some cases, shrink them - all while showing signs that the rest of the body would be spared toxic side effects.
› Verified 8 days ago
Mrs. Jennifer Rae Ambrose, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4100 Lake Otis Pkwy, Suite 222, Anchorage, AK 99508 Phone: 612-269-1918 | |
Waldron Upham, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4100 Lake Otis Pkwy, Anchorage, AK 99508 Phone: 907-550-6110 | |
Tara Mccutcheon, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2801 Debarr Rd, Anchorage, AK 99508 Phone: 801-915-1873 | |
Bucky M Frost, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508 Phone: 907-729-3971 Fax: 907-729-1542 | |
Suzanne C Firth, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Avenue, Anchorage, AK 99506 Phone: 907-580-1815 | |
Mrs. Alicia Marie Ferguson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 611 Clipper Ship Ct, Anchorage, AK 99515 Phone: 907-306-1274 | |
Angela Malcom, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 4100 Lake Otis Pkwy, Anchorage, AK 99508 Phone: 907-550-6110 |